Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2510948 Title: INHIBITEUR D'ACTIVATION DES LYMPHOCYTES T, COMPOSITION PHARMACEUTIQUE CONTENANT CELUI-CI, ET PROCÉDÉ DE CRIBLAGE POUR UNE SUBSTANCE INHIBANT L'ACTIVATION DES LYMPHOCYTES T

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
108359795
WO application number:
JP2010071965
Type:
European patent granted for BE
Status:
Revoked
Publication number:
2510948
WO publication number:
WO2011071059
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
08/12/2010
Grant date:
09/09/2015
EP publication date:
17/10/2012
WO publication date:
16/06/2011
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
09/09/2015
EP B1 publication date:
09/09/2015
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
08/12/2030
Revocation Date:
07/04/2022

Applicant

Name:
Mitsubishi Tanabe Pharma Corporation
Legal Form:
From:
09/09/2015
Address:
3-2-10, Dosho-machi, Chuo-ku, Osaka-shi, Osaka 541-8505, Japan (JP)
To:

Inventor

1

Name:
YAMASHITA, Toshihide
Legal Form:
Address:
Suita-shi Osaka 565-0871, Japan (JP)

2

Name:
KUBO, Takekazu
Legal Form:
Address:
Chiba-shi Chiba 260-8670, Japan (JP)

Priority

Priority patent number:
2009279189
Priority date:
09/12/2009
Priority country:
Japan (JP)

Classification

IPC or IDT classification:
A61K 31/07; A61K 31/122; A61K 31/355; A61K 31/375; A61K 31/7088; A61K 33/00; A61K 33/04; A61K 33/06; A61K 33/26; A61K 33/30; A61K 39/00; A61K 39/395; A61K 45/00; A61P 43/00; C07K 16/18; C07K 16/22; C07K 16/28; C12N 15/113;

Publication

Bulletin

Bulletin heading:
VRV
Journal edition number:
2022/23
Publication date:
04/01/2023
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

European Patent Bulletin

1

Issue number:
201537
Publication date:
09/09/2015
Description:
Grant (B1)

2

Issue number:
201628
Publication date:
13/07/2016
Description:
Opposition procedure started

3

Issue number:
202250
Publication date:
14/12/2022
Description:
Revocation of the European patent

4

Issue number:
201829
Publication date:
18/07/2018
Description:
International Patent Classification Changed

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type